agilon health First Quarter 2025 Earnings: Beats Expectations

agilon health (NYSE:AGL) First Quarter 2025 Results

Key Financial Results

• Revenue: US$1.53b (down 4.5% from 1Q 2024).
• Net loss: US$1.89m (down by 159% from US$3.22m profit in 1Q 2024).
• US$0.005 loss per share (down from US$0.008 profit in 1Q 2024).

Our free stock report includes 2 warning signs investors should be aware of before investing in agilon health. Read for free now.

All figures shown in the chart above are for the trailing 12 month (TTM) period

agilon health Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 1.8%. Earnings per share (EPS) also surpassed analyst estimates.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are down 20% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 2 warning signs for agilon health you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.